หุ้นปันผลสูงในกลุ่มการแพทย์สามตัวที่น่าถือครอง

Pfizer offers a high forward dividend yield of 7.1% and is expected to benefit from products like Padcev and Abrysvo, along with a promising pipeline.

Novo Nordisk remains a leader in diabetes and weight loss markets with advancing candidates and diversification into rare blood diseases.

Sanofi is driven by strong Dupixent performance and pipeline prospects like frexalimab with potential peak sales over $1 billion.